Literature DB >> 25431489

Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Timothy J Nice1, Megan T Baldridge1, Broc T McCune1, Jason M Norman1, Helen M Lazear2, Maxim Artyomov1, Michael S Diamond3, Herbert W Virgin4.   

Abstract

Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-α (IFN-α) and IFN-β prevented the systemic spread of murine norovirus (MNoV), only IFN-λ controlled persistent enteric infection. Infection-dependent induction of IFN-λ was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-λ cured mice in a manner requiring nonhematopoietic cell expression of the IFN-λ receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-λ for curing virus infections in the gastrointestinal tract.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25431489      PMCID: PMC4398891          DOI: 10.1126/science.1258100

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  30 in total

Review 1.  The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors.

Authors:  Tadatsugu Taniguchi; Akinori Takaoka
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

2.  STAT1-dependent innate immunity to a Norwalk-like virus.

Authors:  Stephanie M Karst; Christiane E Wobus; Margarita Lay; John Davidson; Herbert W Virgin
Journal:  Science       Date:  2003-03-07       Impact factor: 47.728

3.  Enteric viruses in healthy children in Cameroon: viral load and genotyping of norovirus strains.

Authors:  James Ayukekbong; Magnus Lindh; Nancy Nenonen; Ferdinand Tah; Theresa Nkuo-Akenji; Tomas Bergström
Journal:  J Med Virol       Date:  2011-12       Impact factor: 2.327

4.  Nosocomial transmission of norovirus is mainly caused by symptomatic cases.

Authors:  Faizel H A Sukhrie; Peter Teunis; Harry Vennema; Cedrick Copra; Matthias F C Thijs Beersma; Jolanda Bogerman; Marion Koopmans
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

5.  Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo.

Authors:  David W Strong; Larissa B Thackray; Tom J Smith; Herbert W Virgin
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

6.  Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line.

Authors:  Kyeong-Ok Chang; Stanislav V Sosnovtsev; Gaël Belliot; Adriene D King; Kim Y Green
Journal:  Virology       Date:  2006-07-14       Impact factor: 3.616

7.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.

Authors:  Kyeong-Ok Chang; David W George
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Nondegradative role of Atg5-Atg12/ Atg16L1 autophagy protein complex in antiviral activity of interferon gamma.

Authors:  Seungmin Hwang; Nicole S Maloney; Monique W Bruinsma; Gautam Goel; Erning Duan; Lei Zhang; Bimmi Shrestha; Michael S Diamond; Adish Dani; Stanislav V Sosnovtsev; Kim Y Green; Carlos Lopez-Otin; Ramnik J Xavier; Larissa B Thackray; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2012-04-19       Impact factor: 21.023

10.  Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages.

Authors:  Christiane E Wobus; Stephanie M Karst; Larissa B Thackray; Kyeong-Ok Chang; Stanislav V Sosnovtsev; Gaël Belliot; Anne Krug; Jason M Mackenzie; Kim Y Green; Herbert W Virgin
Journal:  PLoS Biol       Date:  2004-11-30       Impact factor: 8.029

View more
  174 in total

1.  Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.

Authors:  Joana Rocha-Pereira; Jana Van Dycke; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Persistence of Systemic Murine Norovirus Is Maintained by Inflammatory Recruitment of Susceptible Myeloid Cells.

Authors:  Jacob A Van Winkle; Bridget A Robinson; A Mack Peters; Lena Li; Ruth V Nouboussi; Matthias Mack; Timothy J Nice
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

3.  A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.

Authors:  Sanghyun Lee; Hejun Liu; Craig B Wilen; Zoi E Sychev; Chandni Desai; Barry L Hykes; Robert C Orchard; Broc T McCune; Ki-Wook Kim; Timothy J Nice; Scott A Handley; Megan T Baldridge; Gaya K Amarasinghe; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2019-05-23       Impact factor: 21.023

4.  Comparative Transcriptomic Response of Primary and Immortalized Macrophages to Murine Norovirus Infection.

Authors:  Eric A Levenson; Craig Martens; Kishore Kanakabandi; Charles V Turner; Kimmo Virtaneva; Monica Paneru; Stacy Ricklefs; Stanislav V Sosnovtsev; Jordan A Johnson; Stephen F Porcella; Kim Y Green
Journal:  J Immunol       Date:  2018-05-07       Impact factor: 5.422

5.  Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.

Authors:  Helen M Lazear; Brian P Daniels; Amelia K Pinto; Albert C Huang; Sarah C Vick; Sean E Doyle; Michael Gale; Robyn S Klein; Michael S Diamond
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

6.  MAVS-dependent host species range and pathogenicity of human hepatitis A virus.

Authors:  Asuka Hirai-Yuki; Lucinda Hensley; David R McGivern; Olga González-López; Anshuman Das; Hui Feng; Lu Sun; Justin E Wilson; Fengyu Hu; Zongdi Feng; William Lovell; Ichiro Misumi; Jenny P-Y Ting; Stephanie Montgomery; John Cullen; Jason K Whitmire; Stanley M Lemon
Journal:  Science       Date:  2016-09-15       Impact factor: 47.728

Review 7.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

8.  Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.

Authors:  Yee Ching Ng; Ye Won Kim; Jeong-Su Lee; Sung Joon Lee; Moon Jung Song
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

Review 9.  Viruses in Rodent Colonies: Lessons Learned from Murine Noroviruses.

Authors:  Stephanie M Karst; Christiane E Wobus
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

10.  Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.

Authors:  Ellen Witte; Georgios Kokolakis; Katrin Witte; Katarzyna Warszawska; Markus Friedrich; Demetrios Christou; Stefan Kirsch; Wolfram Sterry; Hans-Dieter Volk; Robert Sabat; Kerstin Wolk
Journal:  J Mol Med (Berl)       Date:  2015-11-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.